Detailing Healthcare Claims Data Evidence of Extrapyramidal Symptoms in Medicaid Patients with Schizophrenia after Second-Generation Antipsychotic Medication Initiation.

Researchers have used elements of administrative healthcare claims data (e.g., diagnosis codes and medications) to calculate rates of extrapyramidal symptoms (EPS) in patients with schizophrenia who utilize second-generation antipsychotics (SGAs). However, a detailed description of claims-based EPS...

Descripción completa

Detalles Bibliográficos

Publicado en:	Community Mental Health Journal Vol. 61; no. 3; pp. 432 - 440
Autores principales:	Richards, Kristin, Johnsrud, Michael, Zacker, Christopher, Sasané, Rahul
Formato:	Artículo
Publicado:	Springer Nature Apr2025
Materias:	Medicaid Medical care costs Drug therapy for schizophrenia Health insurance reimbursement Statistical significance Research funding Antipsychotic agents Chi-squared test Mann Whitney U Test Descriptive statistics Kaplan-Meier estimator Research methodology Basal ganglia diseases Data analysis software
Acceso en línea:	Ver este registro en EBSCOhost